List one potential drug-drug interaction to consider when prescribing Albendazole.

When prescribing Albendazole, one important consideration is that it may interact with drugs metabolized by the cytochrome P450 enzyme system. Albendazole undergoes hepatic metabolism, primarily through the CYP3A4 isozyme. Therefore, if a patient is taking other medications that are also metabolized by CYP3A4, Albendazole could potentially alter the metabolism of those drugs, leading to either increased toxicity or diminished effectiveness. This interaction necessitates careful monitoring and possibly dose adjustments of the concomitant medications.

In contrast, while there are valid considerations surrounding anticoagulants, oral contraceptives, and calcium channel blockers, the direct interaction with cytochrome P450 enzymes is a well-established pharmacokinetic concern that clinicians must explicitly recognize when managing a patient's medication regimen.